August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
James Davis: Dexamethasone for CRS with teclistamab in R/R Multiple Myeloma
Mar 5, 2025, 12:14

James Davis: Dexamethasone for CRS with teclistamab in R/R Multiple Myeloma

James DavisAssistant professor and malignant hematology pharmacist at MUSC Hollings Cancer Center, shared an article he and his colleagues authored on X:

“Hot off the press!

Dexamethasone for CRS with teclistamab. You don’t need toci for grade 1 CRS! great team work.”

Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma

Authors: James Davis et al.

multiple myeloma

 

Rahul Banerjee, Assistant professor at Fred Hutchinson Cancer Center at the University of Washington, reshared the post on X, adding:

“Congrats James Davis et al for great Blood Cancer Journal work!

Consider prescribing “pocket dex” for patients following Multiple Myeloma bsAbs. 10mg for Gr1 CRS after ing with team. Easier for pts, easier for centers, works well, and much cheaper than toci!”